Dr. Graham Edwin Abra, MD

Dr. Abra practices at Redwood City Medical Center in Redwood City, California, part of Kaiser Permanente.

Dr. Abra's NPI, 1760644678, was assigned on July 1, 2008. Dr. Abra graduated from UC San Diego School of Medicine in 2006. Dr. Abra's California license number on file is A102026.

Dr. Abra's primary practice is Redwood City Medical Center, at 1100 Veterans Boulevard, Redwood City, CA 94063 in San Mateo County. The practice phone is (650) 299-2000.

Dr. Abra's primary practice is Redwood City Medical Center in Redwood City, California, part of Kaiser Permanente. Dr. Abra is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Abra to 1 more hospital, 3 dialysis centers and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abra practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Abra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Abra is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abra's licenses on file in 2 states: California and Tennessee.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Abra treats.

CMS data shows 968 Medicare services from Dr. Abra across 11 procedure codes in 2024, for 308 Medicare patients. Medicare paid $99,136 for them.

CMS counts 308 Medicare patients who saw Dr. Abra in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 4.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abra's median patient age at 61, with 48% women.

In 2024, Dr. Abra wrote 989 Medicare Part D claims for 138 patients. 72% of them were for generic drugs. CMS names the drug for 808 of them, across 30 drugs with 11 or more claims each, at $256,567 in total drug cost. In 2023, CMS named 317 claims across 15 drugs.

Dr. Abra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abra as offering telehealth.

Dmand AI links 35 papers to Dr. Abra, published from 2019 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Hemodialysis, Home. Dr. Abra has published most often in Perit Dial Int. Dr. Abra's most frequent co-authors are Glenn Matthew Chertow, MD, Michael A. Aragon, MD and Shuchi Md Anand, MD.

Dmand AI links Dr. Abra to 1 clinical trial.

CMS Open Payments shows 54 general payments to Dr. Abra from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Akebia Therapeutics Inc paid the most, $6,040.

Dr. Abra graduated from UC San Diego School of Medicine in 2006.

Dr. Abra is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.